Genetic study and analysis of family history play a key role in the early diagnosis of cancer Published on 31/01/2023 In the case of a suspected hereditary cancer, annual monitoring of the patient allows the tumor to be detected at an early stage, which means a better prognosis
Un 10% de los cánceres se puede prevenir gracias a los estudios genéticos Published on 18/01/2022 Los pacientes que hayan padecido más de un tipo de cáncer o aquellas personas cuya familia presente más casos de cáncer de lo estadísticamente razonable, son los principales candidatos para realizar un estudio genético
Patients with sarcoma 'play' their best or worst prognosis in the first operation Published on 10/02/2020 22% of people diagnosed with cancer in Spain have a rare tumour, according to data from the Spanish Orphan and Infrequent Tumours Group (GETHI). In these cases, as with other rare diseases, the main problems are delayed diagnosis, reduced availability of therapeutic options and, above all, the difficulty of finding professionals who are experts in a disease that only affects a small part of the population.
Up to 95% of tumours are not hereditary Published on 13/01/2020 According to estimates by the Spanish Cancer Registers Network (REDECAN), at the end of 2019 more than 275,000 cases of cancer were diagnosed in our country
Dr. Ricardo Cubedo, new head of Sarcomas and Hereditary Cancer at MD Anderson Cancer Center Madrid – Hospiten Published on 16/07/2019 Dr. Cubedo is a member of the Spanish Breast Cancer Research Group (GEICAM) and Sarcomas (GEIS), as well as a designated expert with the European Medicines Agency (EMA), among other leading positions